PF-03526299

DRUG2 trials

Sponsors

Pfizer

Conditions

AsthmaHealthy

Phase 1

A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

CompletedNCT00877539

Start: 2009-06-30End: 2010-07-31Updated: 2010-09-28

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers

CompletedNCT00990756

Start: 2009-11-30End: 2010-01-31Target: 24Updated: 2010-01-22